«Our novel miRNA panel might also shed light on the underlying mechanisms of treatment resistance in prostate cancer.» (sciencedaily.com)
Andy Minn, MD, PhD, assistant professor of radiation and cellular oncology An investigator at the Ludwig Center, Minn focuses research on the molecular mechanisms of treatment resistance and is currently developing new diagnostic tools that will identify tumors that are likely to resist therapy. (uchospitals.edu)
«HER3 has been associated with treatment resistance in several types of cancer, and our findings indicate that the overexpression of HER3 within the microenvironment of brain metastases reprograms the signaling pathways shut down by HER2 suppression,» says co-first author Ferraro. (sciencedaily.com)